Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven L Flamm

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Clinics in Liver Disease|July 22, 2015
Covert Hepatic Encephalopathy: Who Should Be Tested and Treated?Steven L Flamm
Clinical Liver Disease|May 2, 2019
Velpatasvir y sofosbuvir: ¿Por qué utilizar un fármaco nuevo si los antiguos funcionan bien?Steven L Flamm
Gastroenterology & Hepatology|April 26, 2014
Commentary: sofosbuvir for treatment of hepatitis C virus genotype 2 or 3 infection in patients without treatment optionsSteven L Flamm
The Journal of Family Practice|April 5, 2017
Hot Topics in Primary Care: Diagnosis of Cirrhosis and Evaluation of Hepatic Encephalopathy: Common Errors and Their Significance for the PCPSteven L Flamm
Clinics in Liver Disease|October 9, 2017
Consultations in Liver DiseaseSteven L Flamm
JAMA|May 15, 2003
Chronic hepatitis C virus infectionSteven L Flamm
The American Journal of Managed Care|March 10, 2018
Considerations for the cost-effective management of hepatic encephalopathySteven L Flamm
Clinics in Liver Disease|July 5, 2020
Consultations in Liver DiseaseSteven L Flamm
Therapeutic Advances in Gastroenterology|June 23, 2011
Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrenceSteven L Flamm
The American Journal of the Medical Sciences|October 6, 2018
Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic EncephalopathySteven L Flamm
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Clinics in Liver Disease|July 22, 2015
Covert Hepatic Encephalopathy: Who Should Be Tested and Treated?Steven L Flamm
Clinical Liver Disease|May 2, 2019
Velpatasvir y sofosbuvir: ¿Por qué utilizar un fármaco nuevo si los antiguos funcionan bien?Steven L Flamm
Gastroenterology & Hepatology|April 26, 2014
Commentary: sofosbuvir for treatment of hepatitis C virus genotype 2 or 3 infection in patients without treatment optionsSteven L Flamm
The Journal of Family Practice|April 5, 2017
Hot Topics in Primary Care: Diagnosis of Cirrhosis and Evaluation of Hepatic Encephalopathy: Common Errors and Their Significance for the PCPSteven L Flamm
Clinics in Liver Disease|October 9, 2017
Consultations in Liver DiseaseSteven L Flamm
JAMA|May 15, 2003
Chronic hepatitis C virus infectionSteven L Flamm
The American Journal of Managed Care|March 10, 2018
Considerations for the cost-effective management of hepatic encephalopathySteven L Flamm
Clinics in Liver Disease|July 5, 2020
Consultations in Liver DiseaseSteven L Flamm
Therapeutic Advances in Gastroenterology|June 23, 2011
Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrenceSteven L Flamm
The American Journal of the Medical Sciences|October 6, 2018
Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic EncephalopathySteven L Flamm
Pageof 7